Elevated levels of IL-6 and IL-17 have been related to pulmonary fibrosis, and the elements of the IL-17A signaling cascade may serve as possible treatment targets for the treatment of fibroproliferative lung disorders [32]. Here, IL6 is linked to pulmonary fibrosis.